Absci to Participate in the UBS Genomics 2.0 and MedTech Innovations Summit ConferenceGlobeNewsWire • 08/01/22
Absci to Participate in the SVB Securities CybeRx: Big Data, A.I. & Machine Learning in Healthcare EventGlobeNewsWire • 07/21/22
Absci Prepares for Next Stage of Growth with Executive Human Resources and Marketing HiresGlobeNewsWire • 07/14/22
Viva Biotech Announced 2021 Annual Results: Revenue Increased by 201.9% YoY, CRO Business Revenue Maintained Rapid Growth with an Increase of 68.7%PRNewsWire • 03/28/22
Absci Develops Groundbreaking Machine Learning Models for In-Silico Antibody Design, Powered by NVIDIAGlobeNewsWire • 03/22/22
Absci to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools ConferenceGlobeNewsWire • 02/11/22
ABSI Stock: 7 Things for Investors to Know About the Merck Deal That Has Absci Shares Flying TodayInvestorPlace • 01/07/22
Absci stock rockets after collaboration with Merck could lead to more than $600 million in paymentsMarket Watch • 01/07/22
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors Absci Corporation - ABSINewsfile Corp • 11/29/21